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Mutations in keratin genes underlie a variety of epidermal and non-epidermal cell-
fragility disorders and are the genetic basis of many inherited palmoplantar 
keratodermas.
 
Epidermolytic PPK (EPPK) is an autosomal dominant disorder that can 
be due to mutations in the keratin 1 gene (KRT1).
 
Epidermolytic ichthyosis (EI), the 
major keratinopathic ichthyosis, is characterized by congenital erythroderma, 
blistering and erosions of the skin. Causative mutations in KRT1 and KRT10 have 
been described, with PPK being present primarily in association with the former. We 
report four unrelated cases - one with sporadic EI and three with autosomal dominant 
PPK, due to two novel and two recurrent KRT1 mutations. Mutations in KRT1 are not 
only scattered throughout keratin 1, as opposed to being clustered, but can result in a 












































































Keratins constitute the intermediate filament proteins of keratinocytes, with the 
keratin cytoskeleton acting as an important structural stabilizer of epithelial cells.
1
 
Mutations in keratin genes underlie a variety of epidermal and non-epidermal cell-
fragility disorders and are the genetic basis of a number of the inherited palmoplantar 
keratodermas (PPKs).
2
 Epidermolytic PPK (EPPK; Vorner type; OMIM 144200) is an 
autosomal dominant disorder that can be caused by dominant-negative mutations in 
the keratin 1 gene (KRT1).
3
 Epidermolytic ichthyosis (EI; EHK; BCIE; OMIM 
113800), the major keratinopathic ichthyosis, is characterized by congenital 
erythroderma, blistering and erosions of the skin.
4
 Causative mutations in KRT1 and 
KRT10 have been described, with PPK being present primarily in association with the 
former. 
We report four unrelated cases with KRT1 mutations - one with sporadic EI and three 
with autosomal dominant PPK, due to two previously unreported and two recurrent 
KRT1 mutations.  
 
Report 
Genetic testing was performed with informed consent and ethical approval by an 
Institutional Review Board that complies with principles of the Helsinki Accord. 
Genomic DNA was extracted from peripheral blood leukocytes or from saliva 
collected in an Oragene DNA sample collection kit (DNA Genotek, Ontario, Canada). 
PCR and Sanger sequencing was performed to screen the coding regions and 
exon/intron boundaries of KRT1 (primer sequences available on request). Variants 
were confirmed as pathogenic by reference to the in silico prediction tool, Mutation 
Taster and by sequencing other family members when available. None of the variants 






























































were present on the database of Single Nucleotide Polymorphisms (dbSNP), 1000 
Genome Project, NHLBI Exome Variant Server, Exome Aggregation Consortium 
(ExAC) or the Genome Aggregation Database (gnomAD).   
 
Cases: Families 1 and 4 presented to their local dermatology services. Families 2 and 
3 were identified through the International Pachyonychia Congenita Research 
Registry. All reported PPK since early childhood with a positive family history in 
cases 2, 3 and 4. No affected individuals had a history of collodion membrane, hair, 
teeth or cardiac abnormalities.  
              In family 1, the 23-year-old wheelchair-bound proband presented as an adult 
with diffuse hyperkeratosis on his trunk and limbs in addition to acral sites, having 
failed to seek medical attention for many years. Skin fragility and blistering were 
reported at sites of trauma, with a history of blistering, scaling and erythroderma 
being present from birth. Severe flexion contractures of the fingers and toes were 
evident, with surgical correction considered limited in terms of benefit (Fig.1a-c). 
Osteopenia, chronic pain, and the psychological impact of his debilitating skin disease 
resulting in social isolation and childhood bullying necessitated a multidisciplinary 
management approach. There was no known family history, although the proband was 
estranged from most close relatives so further clinical and genetic information was 
unobtainable. Mutation analysis of the proband in family 1 identified a previously 
unreported heterozygous missense mutation in exon 1 of the keratin 1, p.Leu187Pro; 
c.560T>C; (Figs. 1d,e and 4). DNA was not available from any other family 
members. This mutation is within the 1A domain of keratin 1 and another pathogenic 
variant has previously been reported at the same codon, p.Leu187Phe in two cases 
with typical EI (Table 1, www.interfil.org).
5
 






























































The 39-year-old female proband of family 2 presented with a history of 
diffuse keratoderma of bilateral palms and plantar feet with sharp demarcation and 
yellow hue since early childhood, with milder callosities and fissuring affecting the 
palms and fingertips (Fig. 2a-c). Her older brother, mother and maternal grandmother 
all had similar findings. A previously unreported mutation, p.Leu485Phe; c.1453C>T 
(Figs. 2d,e and 4) was identified in exon 7 of KRT1 in the proband of family 2. The 
mutation was present in two other affected family members, her brother and mother. 
Another pathogenic missense mutation has previously been reported at this position in 
the 2B domain of keratin 1, p.Leu485Pro; c.1454T>C in a case with PPK (Table 1).
6
 
In Family 3, the 43-year-old female proband had diffuse well-demarcated 
plantar hyperkeratosis with slightly erythematous borders since infancy (Fig. 3 a,b). 
Fissuring hyperkeratosis of the palms and fingertips was present but no nail 
dystrophy, transgrediens or blistering. Her father, paternal grandmother, paternal 
great-grandmother, and paternal great-aunt all had similar symptoms. The proband of 
family 3 was found to have a mutation in the 1B domain of KRT1, p.Ser233Leu; 




The 32-year-old proband in family 4 had diffuse plantar and palmar 
hyperkeratosis which peeled significantly once acitretin 20mg od was introduced (Fig. 
3 c-f). Her grandmother, mother, son and daughter were similarly affected. Analysis 
of the proband in family 4 identified recurrent pathogenic mutation c.1254+1G>A 
causing a splice site mutation in exon 6, leading to utilization of a novel in-frame 
splice site 54 bases downstream with subsequent insertion of 18 amino acids into the 
2B rod domain, p.Gln418_Ile419ins18, previously reported in association with EPPK 
(Table 1, Fig 4).
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Keratin intermediate filaments are characterized by tissue-specific expression 
patterns, with the cell-type and tissue-specific expression profile of the mutated 
keratin dictating the cell type and body site that is affected in the disorder.
2
 KRT1 and 
KRT10 confer structural integrity to suprabasal keratinocytes and mutations impair 
the assembly of the keratin cytoskeleton. In some keratin disorders such as 
pachyonychia congenita, keratin mutations are predominantly clustered to the helix 
boundary domains at either end of the rod domain. However, the 84 cases previously 
reported with mutations in KRT1 (www.interfil.org) show that mutations in KRT1 are 
not only scattered throughout keratin 1 as shown in Fig. 4 but can result in a range of 
phenotypes
6
 as further confirmed by these mutations, giving a complex 
genotype/phenotype pattern. A wide range in phenotypic severity is also reported in 
association with KRT1 mutations particularly in EI
7,8
. Mutations in the keratin 9 gene 
(KRT9) also cause epidermolytic PPK (EPPK). With the development of new gene 
and mutation-specific therapies for inherited disorders of keratinization, it is 
becoming increasingly important to accurately document both genotype and 
phenotype.  Our cases add to the mutational and clinical spectrum and demonstrate 
wide phenotypic variation in KRT1 mutations, despite their unifying molecular basis.  
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Figure 1. Clinical features and mutation analysis of family 1  
(a) hyperkeratosis of the proband’s digits and palm 
 (b) diffuse plantar hyperkeratosis  
(c) warty flexural hyperkeratosis  
(d) wild-type KRT1 sequence of exon 1 (nucleotides 553-567) 
e) the equivalent region of KRT1 from the proband of family 1. The arrow indicates a 
heterozygous mutation c.560T>C resulting in an amino acid substitution of leucine to 
proline, p.Leu187Pro, in the keratin 1 protein 
Figure 2. Clinical features and mutation analysis of family 2  
(a, b) diffuse plantar (c) palmar keratoderma of the proband 
(d) mutation analysis showing DNA sequence (nucleotides 1447-1461) of exon 7 of 
KRT1 in an unaffected control compared to (e) the same region of KRT1 in the 
proband of family 2. The arrow indicates a het rozygous mutation c.1453C>T leading 
to missense mutation p.Leu485Phe. 
Figure 3. Clinical features of families 3 and 4 
(a and b) diffuse well-demarcated plantar hyperkeratosis with slightly erythematous 
border of the proband of family 3, with mutation K1 p.Ser233Leu. 
(c) diffuse hyperkeratosis of palms of proband and daughter from family 4, with 
mutation K1 p.Gln418_Ile419ins18. 
(d) peeling of skin on the palm associated with oral acitretin therapy; 
(e, f) diffuse hyperkeratosis of the soles with some sparing of the arch of proband of 
family 4. 






























































Figure 4. Schematic diagram showing the protein domain structure of keratin 1 and 
previously reported mutations. Those from this study are included; novel mutations 
are shown in red and recurrent ones in blue. 
Table 1. Molecular and clinical details of cases in this study (novel and recurrent, in 




• Mutations in keratin genes underlie a variety of epidermal and non-epidermal 
cell-fragility disorders and are the genetic basis of a number of the inherited 
palmoplantar keratodermas. 
• Epidermolytic PPK (OMIM 144200) is an autosomal dominant disorder 
usually caused by mutations in the keratin 9 gene (KRT9) but mutations in the 
keratin 1 gene (KRT1) have been reported in association with this phenotype. 
• Epidermolytic ichthyosis (OMIM 113800), the major keratinopathic 
ichthyosis, is characterized by congenital erythroderma, blistering and 
erosions of the skin. 
• Causative mutations in KRT1 and KRT10 have been described in 
epidermolytic ichthyosis, with PPK being present primarily in association with 
the former. 
• Mutations in KRT1 are not only scattered throughout keratin 1 but can result in 
a range of phenotypes as further confirmed by these mutations, giving a 
complex genotype/phenotype pattern. 






























































• This report adds to the mutational and clinical spectrum, demonstrating wide 
phenotypic variation in KRT1 mutations, despite their unifying molecular 
basis. 
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(d) Wild type K1, exon 1 (e) K1 p.Leu187Pro 

































































(d) Wild type K1, exon 7 (e) K1 p.Leu485Phe 
Figure 2 































































(a) Family 3 K1 p.Ser233Leu 
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Figure 4. Schematic diagram showing the protein domain structure of keratin 1 and previously reported mutations. 
Those from this study are included; novel mutations are shown in red and recurrent ones in blue. 
 






























































Table 1. Molecular and clinical details of cases in this study (novel and recurrent,  in bold) compared with previously reported cases.
Family Mutation - protein change DNA change Exon Keratin domain Clinical description Reference
Family 1 p.Leu187Pro c.560T>C 1 1A
EI, spontaneous case, with a history of blistering, scaling and 
erythema since birth. As an adult, diffuse hyperkeratosis on trunk,  
limbs and acral sites.
this study
(novel mutation)
p.Leu187Phe c.559C>T 1 1A
EI, spontaneous case with erythroderma, erosions, and blisters on the 
entire body surface at birth and palmoplantar and flexural areas of 
hyperkeratosis in the later stage.
Ref 5
www.interfil.org
p.Leu187Phe c.559C>T 1 1A




Family 2 p.Leu485Phe c.1453C>T 7 2B




p.Leu485Pro c.1454T>C 7 2B Generalised severe EI including PPK (mother, EI naevus). Ref 6
Family 3 p.Ser233Leu c.698C>T 2 1B
PPK - familial case with diffuse well-demarcated plantar 
hyperkeratosis with slightly erythematous borders since infancy. 
Fissuring hyperkeratosis of the palms and fingertips.
this study
(recurrent mutation)
p.Ser233Leu c.698C>T 2 1B
EPPK  (Vörner type), familial case with diffuse PPK with a well-




p.Ser233Leu c.698C>T 2 1B
EPPK  (Vörner type), familial case with diffuse PPK with a well-




p.Ser233Leu c.698C>T 2 1B
EPPK Vörner - familial case with diffuse yellowish hyperkeratosis on 
palms & soles developed shortly after birth, with a clear border & 
demarcated by an erythematous rim.
Ref 5
www.interfil.org
p.Ser233Leu c.698C>T 2 1B
EPPK Vörner - familial case with diffuse yellowish hyperkeratosis on 
palms & soles developed shortly after birth, with a clear border & 
demarcated by an erythematous rim.
Ref 5
www.interfil.org
p.Ser233Leu c.698C>T 2 1B EPPK  (Vörner type), developed shortly after birth.  Ref 8
Family 4 p.Gln418_Ile419ins18 c.1254+1G>A 6 2B
PPK - familial case with diffuse palmoplantar hyperkeratosis that 
developed shortly after birth. 
this study
(recurrent mutation)
p.Gln418_Ile419ins18 c.1254+1G>A 6 2B
EPPK - familial case, hyperkeratosis restricted to the palms and soles 
developed in childhood. Varying severity between family members 
from patchy plantar keratoderma to confluent plantar keratoderma. A 
violaceous erythematous border was observed at the edge of the 
keratoderma in severe cases.
Ref 3
p.Gln418_Ile419ins18 c.1254+1G>A 6 2B
EPPK - familial case, hyperkeratosis restricted to the palms and soles 
developed in childhood. Varying severity between family members 
from patchy plantar keratoderma to confluent plantar keratoderma. A 
violaceous erythematous border was observed at the edge of the 
keratoderma in severe cases.
Ref 3
p.Gln418_Ile419ins18 c.1254+1G>A 6 2B
EPPK - familial case, hyperkeratosis restricted to the palms and soles 
developed in childhood. Varying severity between family members 
from patchy plantar keratoderma to confluent plantar keratoderma. A 
violaceous erythematous border was observed at the edge of the 
keratoderma in severe cases.
Ref 3
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